Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20016520 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment
Conditions: Obstructive Sleep Apnea;   Resistant Hypertension;   Hyperaldosteronism
Interventions: Drug: Spironolactone;   Drug: BP medication uptitration

Indicates status has not been verified in more than two years